Citalopram tablets
Reason category: Labeling or packaging error
FDA recall number D-0173-2024
Mental health
Citalopram 20 mg tablet
Public data on citalopram from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.0303
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
+2%
change over five years
peak $0.0393 in 2014-02
33
approved generic applications (ANDAs) on record for Citalopram Hydrobromide
12 with a product still marketed · first 2004
Not listed
in FDA's current shortage list
no matching FDA shortage entries
NADAC per unit, monthly
CITALOPRAM HBR 20 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.03213 |
| 2014-02 | 0.03934 |
| 2014-05 | 0.03371 |
| 2014-08 | 0.03402 |
| 2014-11 | 0.03230 |
| 2015-02 | 0.03241 |
| 2015-05 | 0.03244 |
| 2015-08 | 0.03159 |
| 2015-11 | 0.03014 |
| 2016-02 | 0.03129 |
| 2016-05 | 0.03112 |
| 2016-08 | 0.03001 |
| 2016-11 | 0.03238 |
| 2017-02 | 0.03226 |
| 2017-05 | 0.03300 |
| 2017-08 | 0.03202 |
| 2017-11 | 0.03284 |
| 2018-02 | 0.03064 |
| 2018-05 | 0.02927 |
| 2018-08 | 0.02819 |
| 2018-11 | 0.02738 |
| 2019-02 | 0.02749 |
| 2019-05 | 0.02792 |
| 2019-08 | 0.02821 |
| 2019-11 | 0.02915 |
| 2020-02 | 0.02881 |
| 2020-05 | 0.02831 |
| 2020-08 | 0.02978 |
| 2020-11 | 0.02916 |
| 2021-02 | 0.02980 |
| 2021-05 | 0.02976 |
| 2021-08 | 0.03032 |
| 2021-11 | 0.02957 |
| 2022-02 | 0.02830 |
| 2022-05 | 0.02954 |
| 2022-08 | 0.03177 |
| 2022-11 | 0.03198 |
| 2023-02 | 0.02869 |
| 2023-05 | 0.03033 |
| 2023-08 | 0.03214 |
| 2023-11 | 0.03240 |
| 2024-02 | 0.03270 |
| 2024-05 | 0.02798 |
| 2024-08 | 0.02950 |
| 2024-11 | 0.02751 |
| 2025-02 | 0.02893 |
| 2025-05 | 0.03169 |
| 2025-08 | 0.03107 |
| 2025-11 | 0.02974 |
| 2026-02 | 0.02888 |
| 2026-05 | 0.02883 |
| 2026-08 | 0.02872 |
| 2026-11 | 0.03029 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning citalopram
openFDA enforcement records, by year reported.
| 2024 | 1 |
| 2020 | 1 |
| 2016 | 2 |
| 2015 | 1 |
| 2014 | 2 |
| 2013 | 3 |
10 records since 2012. A record is one product or lot, not one recall event. Combination products that contain citalopram are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Citalopram oral solution
Reason category: Impurities (e.g. nitrosamines)
FDA recall number D-0015-2021
Citalopram product
Reason category: Labeling or packaging error
FDA recall number D-1516-201
Citalopram product
Reason category: Other
FDA recall number D-1090-2016
Citalopram product
Reason category: Sterility / contamination
FDA recall number D-591-2015
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention citalopram
4 GxRadar articles cite or discuss this drug.
Price histories · Data story · 6 min
What pharmacies paid for six generic antidepressants, 2013 to 2026
Federal NADAC data for sertraline, escitalopram, citalopram, fluoxetine, trazodone and duloxetine show three very different price paths since 2013, and FDA approval records help explain them.
Labels & identifiers · Explainer · 6 min
Boxed warnings, FDA's most prominent label warning, explained
What 21 CFR 201.57 requires of a boxed warning, how many prescription labels carry one (about a third, by two counts 14 years apart), and why a generic's box matches the brand's.
Benchmarks & how prices are set · Data story · 7 min
The 2024 NADAC swings, and the three-month average that followed
In 2024 the federal benchmark for generic drug costs lurched up and down across nearly every drug at once. Our basket index shows the swings month by month, and what changed when CMS switched to a moving average.
Price histories · Data story · 6 min
The generics that cost pharmacies more than they did in 2014
Most generics in GxRadar's 47-drug basket got cheaper. Seven cost pharmacies more than in January 2014, led by furosemide at 2.8 times its 2014 price. What federal cost and shortage data show, drug by drug.